Palliative care utilization and racial and ethnic disparities among women with de novo metastatic breast cancer in the United States
Tóm tắt
The potential disparities in palliative care delivery for underrepresented minorities with breast cancer are not well known. We sought to determine whether race and ethnicity impact the receipt of palliative care for patients with metastatic breast cancer (MBC). We retrospectively reviewed the National Cancer Database for female patients diagnosed with stage IV breast cancer between 2010 and 2017 who received palliative care following diagnosis of MBC to assess the proportion of patients who received palliative care, including non–curative-intent local–regional or systemic therapy. Multivariable logistic regression analysis was performed to identify variables associated with receiving palliative care. 60,685 patients were diagnosed with de novo MBC. Of these, only 21.4% (n = 12,963) received a palliative care service. Overall, there was a positive trend in palliative care receipt from 18.2% in 2010 to 23.0% in 2017 (P < 0.001), which persisted when stratified by race and ethnicity. Relative to non-Hispanic White women, Asian/Pacific Islander women (aOR 0.80, 95% CI 0.71–0.90, P < 0.001), Hispanic women (adjusted odds ratio [aOR] 0.69, 95% CI 0.63–0.76, P < 0.001), and non-Hispanic Black women (aOR 0.94, 95% CI 0.88–0.99, P = 0.03) were less likely to receive palliative care. Fewer than 25% of women with MBC received palliative care between 2010 and 2017. While palliative care has significantly increased for all racial/ethnic groups, Hispanic White, Black, and Asian/Pacific Islander women with MBC still receive significantly less palliative care than non-Hispanic White women. Further research is needed to identify the socioeconomic and cultural barriers to palliative care utilization.
Tài liệu tham khảo
Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA: Cancer J Clin 71(1):7–33
Geels P, Eisenhauer E, Bezjak A, Zee B, Day A (2000) Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 18(12):2395–2405
Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J et al (2016) Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA 316(20):2104–2114
Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J et al (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 302(7):741–749
Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z et al (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33(13):1438–1445
Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383(9930):1721–1730
Vanbutsele G, Pardon K, Van Belle S, Surmont V, De Laat M, Colman R et al (2018) Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial. Lancet Oncol 19(3):394–404
Grudzen CR, Richardson LD, Johnson PN, Hu M, Wang B, Ortiz JM et al (2016) Emergency department-initiated palliative care in advanced cancer: a randomized clinical trial. JAMA Oncol 2(5):591–598
Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM et al (2017) Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update. J Clin Oncol 35(1):96–112
Ren JX, Gong Y, Ling H, Hu X, Shao ZM (2019) Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics. Breast Cancer Res Treat 173(1):225–237
DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67(6):439–448
Nickolich MS, El-Jawahri A, Temel JS, LeBlanc TW (2016) Discussing the evidence for upstream palliative care in improving outcomes in advanced cancer. Am Soc Clin Oncol Educ Book 35:e534–e538
Deeb S, Chino FL, Diamond LC, Tao A, Aragones A, Shahrokni A et al (2021) Disparities in care management during terminal hospitalization among adults with metastatic cancer from 2010 to 2017. JAMA Netw Open 4(9):e2125328
Commision on Cancer (2023) American college of surgeons optimal resources for cancer care 2020 standards. Feb 2023, pp 1–112. https://accreditation.facs.org/accreditationdocuments/CoC/Standards/Optimal_Resources_for_Cancer_Care_Feb_2023.pdf?_gl=1*2tohlz*_ga*Mjg0ODgwOTMwLjE2ODE0MzYyOTY.*_ga_KBB21NPQBH*MTY4MTQzNjI5NS4xLjAuMTY4MTQzNjMwNS4wLjAuMA..*_ga_6C8S73MC87*MTY4MTQzNjI5NS4xLjAuMTY4MTQzNjMwNS4wLjAuMA..&_ga=2.218035606.167832602.1681436296-1355094836.1681436296. Accessed on 13 Apr 2023
Sheldon LK (2014) Implementing the new commission on cancer standard on palliative care services. Clin J Oncol Nurs 18(Suppl):37–38
American Cancer Society (2021) Cancer Facts & Figures 2021. Atlanta: American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf. Accessed on 13 Apr 2023
Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2020) SEER cancer statistics review, 1975–2017, National Cancer Institute. Bethesda, Apr 2020. https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site. Accessed on 13 Apr 2023
Greer JA, Moy B, El-Jawahri A, Jackson VA, Kamdar M, Jacobsen J et al (2022) Randomized trial of a palliative care intervention to improve end-of-life care discussions in patients with metastatic breast cancer. J Natl Compr Canc Netw 20(2):136–143